Showing results (31-40 of 875) with videos related to
Sort By:
Pageof 88
Cardiovascular & Hematological Disorders Drug Targets|June 10, 2008
Moving troponin testing into the 21st century: will greater sensitivity be met with greater sensibility?Lisa S Rosenbaum, James L JanuzziSouthern Medical Journal|November 15, 2006
Non-ST segment elevation acute coronary syndromes: A comprehensive reviewAbelardo Martinez-Rumayor, James L JanuzziHeart Failure Clinics|July 28, 2009
Natriuretic peptides in the diagnosis and management of acute heart failureAsim A Mohammed, James L JanuzziDrug News & Perspectives|July 18, 2009
Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failureJames L Januzzi, Antoni Bayes-GenisClinical Chemistry|January 8, 2017
Beyond Natriuretic Peptides for Diagnosis and Management of Heart FailureNasrien E Ibrahim, James L JanuzziClinics in Laboratory Medicine|February 10, 2023
Using Artificial Intelligence to Better Predict and Develop BiomarkersSam A Michelhaugh, James L JanuzziClinical Chemistry|December 14, 2020
Sodium-Glucose Co-Transporter 2 Inhibitors and Insights from Biomarker Measurement in Heart Failure PatientsNasrien E Ibrahim, James L JanuzziComprehensive Therapy|January 2, 2010
The emerging role of highly sensitive troponin in the evaluation of acute coronary syndromeAsim A Mohammed, James L JanuzziCurrent Heart Failure Reports|February 23, 2018
The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) StudyNasrien E Ibrahim, James L JanuzziCardiology in Review|October 4, 2012
Using biomarkers to "guide" heart failure management: current perspectives and future directionsShweta R Motiwala, James L JanuzziPageof 88